Patient Guide: A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 39 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04931342
Status: ACTIVE_NOT_RECRUITING
Condition: Ovarian Cancer
Phase: PHASE2

Where You Can Participate

This study is available at 39 locations across the country.

Top locations include:
  • • San Francisco, California
  • • Saint Louis, Missouri
  • • Charlotte, North Carolina
  • • And 36 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors - Join Clinical Trial NCTNCT04931342

How to Join This Clinical Trial - NCTNCT04931342

Learn how to participate in this PHASE2 trial studying an investigational therapy for Ovarian Cancer. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Ovarian Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Ovarian Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04931342 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 39 locations. Find a study site near you:

Clinical Research Site

San Francisco, California 94158 - United States

Status: Contact for availability

Clinical Research Site

Saint Louis, Missouri 63108 - United States

Status: Contact for availability

Clinical Research Site

Charlotte, North Carolina 28204 - United States

Status: Contact for availability

Clinical Research Site

Columbus, Ohio 43210 - United States

Status: Contact for availability

Clinical Research Site

Oklahoma City, Oklahoma 73104 - United States

Status: Contact for availability

Clinical Research Site

The Woodlands, Texas 77380 - United States

Status: Contact for availability

Clinical Research Site

Norfolk, Virginia 23502 - United States

Status: Contact for availability

Clinical Research Site

Seattle, Washington 98109 - United States

Status: Contact for availability

Clinical Research Site

Malvern, Victoria 3144 - Australia

Status: Contact for availability

Clinical Research Site

Toronto, Ontario M5G 1Z5 - Canada

Status: Contact for availability

And 29 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Ovarian Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships